Corrigendum to ‘clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome’ (EBioMedicine (2019) 43 (253–260), (S2352396419302142), (10.1016/j.ebiom.2019.03.069)): Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome’ (EBioMedicine (2019) 43 (253–260), (S2352396419302142), (10.1016/j.ebiom.2019.03.069))

Suzy Scholl; Marina Popovic; Anne de la Rochefordiere; Elodie Girard; Sylvain Dureau; Aljosa Mandic; Katarina Koprivsek; Nina Samet; Marius Craina; Madalin Margan; Sanne Samuels; Henry Zijlmans; Gemma Kenter; Peter Hillemanns; Sorin Dema; Alis Dema; Goran Malenkovic; Branislav Djuran; Anne Floquet; Delphine Garbay; Frédéric Guyon; Pierre Emmanuel Colombo; Michel Fabbro; Christine Kerr; Charlotte Ngo; Fabrice Lecuru; Eleonor Rivin del Campo; Charles Coutant; Frédéric Marchal; Nathalie Mesgouez-Nebout; Virginie Fourchotte; Jean Guillaume Feron; Philippe Morice; Eric Deutsch; Pauline Wimberger; Jean-Marc Classe; Noreen Gleeson; Heiko von der Leyen; Mathieu Minsat; Coraline Dubot; Pierre Gestraud; Attila Kereszt; Istvan Nagy; Balazs Balint; Els Berns; Ekaterina Jordanova; Nicolas de Saint-Jorre; Alexia Savignoni; Nicolas Servant; Philippe Hupe; Leanne de Koning; Pierre Fumoleau; Roman Rouzier; Maud Kamal; Federic Guyon

doi:10.1016/j.ebiom.2020.102875

Corrigendum to ‘clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome’ (EBioMedicine (2019) 43 (253–260), (S2352396419302142), (10.1016/j.ebiom.2019.03.069)): Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome’ (EBioMedicine (2019) 43 (253–260), (S2352396419302142), (10.1016/j.ebiom.2019.03.069))

Suzy Scholl^*
, Marina Popovic
, Anne de la Rochefordiere
, Elodie Girard
, Sylvain Dureau
, Aljosa Mandic
, Katarina Koprivsek
, Nina Samet
, Marius Craina
, Madalin Margan
, Sanne Samuels
, Henry Zijlmans
, Gemma Kenter
, Peter Hillemanns
, Sorin Dema
, Alis Dema
, Goran Malenkovic
, Branislav Djuran
, Anne Floquet
, Delphine Garbay

Frédéric Guyon, Pierre Emmanuel Colombo, Michel Fabbro, Christine Kerr, Charlotte Ngo, Fabrice Lecuru, Eleonor Rivin del Campo, Charles Coutant, Frédéric Marchal, Nathalie Mesgouez-Nebout, Virginie Fourchotte, Jean Guillaume Feron, Philippe Morice, Eric Deutsch, Pauline Wimberger, Jean-Marc Classe, Noreen Gleeson, Heiko von der Leyen, Mathieu Minsat, Coraline Dubot, Pierre Gestraud, Attila Kereszt, Istvan Nagy, Balazs Balint, Els Berns, Ekaterina Jordanova, Nicolas de Saint-Jorre, Alexia Savignoni, Nicolas Servant, Philippe Hupe, Leanne de Koning, Pierre Fumoleau, Roman Rouzier, Maud Kamal, Federic Guyon

^*Corresponding author for this work

Université PSL
Gynecologic Oncology Department Clinic for Operative Oncology, Institute of Oncology of Vojvodina, Sremska, Serbia
University of Novi Sad
Publica Institutul Oncologic, Chișinău, Republic of Moldova
dUniversity of Medicine and Pharmacy "Victor Babeș", Romania
Antoni van Leeuwenhoek Hospital
Hannover Medical School
Centre Georges-François Leclerc
Centre régional de lutte du cancer Val d'Aurelle
Hôpital européen Georges Pompidou
Hôpital Tenon
Université de Lorraine
mInstitut de cancérologie de l'Ouest – site Paul Papin (ICO) 15, Rue André Boquel, 49055 Angers, France
nGustave Roussy, France
Technische Universität Dresden
René Gauducheau, Paris, France
qSt James/Trinity College, Ireland
Hannover Clinical Trial Center GmbH, Hannover, Germany
SeqOmics Biotechnology Ltd.
Erasmus MC
uQuanticsoft, France

Research output: Contribution to journal › Erratum/Corrigendum › Academic

Abstract

The authors wish to clarify that the authors Aljosa Mandic, Katarina Koprivsek, and Goran Malenkovic are also affiliated with Faculty of Medicine Novi Sad, University of Novi Sad, Serbia, as well as Gynecologic Oncology Department Clinic for Operative Oncology, Institute of Oncology of Vojvodina, Serbia.

Original language	English
Article number	102875
Journal	EBioMedicine
Volume	57
DOIs	https://doi.org/10.1016/j.ebiom.2020.102875
Publication status	Published - 1 Jul 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.ebiom.2020.102875

Fingerprint

Dive into the research topics of 'Corrigendum to ‘clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome’ (EBioMedicine (2019) 43 (253–260), (S2352396419302142), (10.1016/j.ebiom.2019.03.069)): Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome’ (EBioMedicine (2019) 43 (253–260), (S2352396419302142), (10.1016/j.ebiom.2019.03.069))'. Together they form a unique fingerprint.

Cite this

Scholl, S., Popovic, M., Rochefordiere, A. D. L., Girard, E., Dureau, S., Mandic, A., Koprivsek, K., Samet, N., Craina, M., Margan, M., Samuels, S., Zijlmans, H., Kenter, G., Hillemanns, P., Dema, S., Dema, A., Malenkovic, G., Djuran, B., Floquet, A., ... Guyon, F. (2020). Corrigendum to ‘clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome’ (EBioMedicine (2019) 43 (253–260), (S2352396419302142), (10.1016/j.ebiom.2019.03.069)): Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome’ (EBioMedicine (2019) 43 (253–260), (S2352396419302142), (10.1016/j.ebiom.2019.03.069)). EBioMedicine, 57, Article 102875. https://doi.org/10.1016/j.ebiom.2020.102875

Scholl, Suzy ; Popovic, Marina ; Rochefordiere, Anne de la et al. / Corrigendum to ‘clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome’ (EBioMedicine (2019) 43 (253–260), (S2352396419302142), (10.1016/j.ebiom.2019.03.069)) : Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome’ (EBioMedicine (2019) 43 (253–260), (S2352396419302142), (10.1016/j.ebiom.2019.03.069)). In: EBioMedicine. 2020 ; Vol. 57.

@article{97de80db301c4ab8a87519bf741f9984,

title = "Corrigendum to {\textquoteleft}clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome{\textquoteright} (EBioMedicine (2019) 43 (253–260), (S2352396419302142), (10.1016/j.ebiom.2019.03.069)): Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome{\textquoteright} (EBioMedicine (2019) 43 (253–260), (S2352396419302142), (10.1016/j.ebiom.2019.03.069))",

abstract = "The authors wish to clarify that the authors Aljosa Mandic, Katarina Koprivsek, and Goran Malenkovic are also affiliated with Faculty of Medicine Novi Sad, University of Novi Sad, Serbia, as well as Gynecologic Oncology Department Clinic for Operative Oncology, Institute of Oncology of Vojvodina, Serbia.",

author = "Suzy Scholl and Marina Popovic and Rochefordiere, \{Anne de la\} and Elodie Girard and Sylvain Dureau and Aljosa Mandic and Katarina Koprivsek and Nina Samet and Marius Craina and Madalin Margan and Sanne Samuels and Henry Zijlmans and Gemma Kenter and Peter Hillemanns and Sorin Dema and Alis Dema and Goran Malenkovic and Branislav Djuran and Anne Floquet and Delphine Garbay and Fr{\'e}d{\'e}ric Guyon and Colombo, \{Pierre Emmanuel\} and Michel Fabbro and Christine Kerr and Charlotte Ngo and Fabrice Lecuru and \{del Campo\}, \{Eleonor Rivin\} and Charles Coutant and Fr{\'e}d{\'e}ric Marchal and Nathalie Mesgouez-Nebout and Virginie Fourchotte and Feron, \{Jean Guillaume\} and Philippe Morice and Eric Deutsch and Pauline Wimberger and Jean-Marc Classe and Noreen Gleeson and Leyen, \{Heiko von der\} and Mathieu Minsat and Coraline Dubot and Pierre Gestraud and Attila Kereszt and Istvan Nagy and Balazs Balint and Els Berns and Ekaterina Jordanova and \{de Saint-Jorre\}, Nicolas and Alexia Savignoni and Nicolas Servant and Philippe Hupe and \{de Koning\}, Leanne and Pierre Fumoleau and Roman Rouzier and Maud Kamal and Federic Guyon",

year = "2020",

month = jul,

day = "1",

doi = "10.1016/j.ebiom.2020.102875",

language = "English",

volume = "57",

journal = "EBioMedicine",

issn = "2352-3964",

publisher = "Elsevier B.V.",

}

Scholl, S, Popovic, M, Rochefordiere, ADL, Girard, E, Dureau, S, Mandic, A, Koprivsek, K, Samet, N, Craina, M, Margan, M, Samuels, S, Zijlmans, H, Kenter, G, Hillemanns, P, Dema, S, Dema, A, Malenkovic, G, Djuran, B, Floquet, A, Garbay, D, Guyon, F, Colombo, PE, Fabbro, M, Kerr, C, Ngo, C, Lecuru, F, del Campo, ER, Coutant, C, Marchal, F, Mesgouez-Nebout, N, Fourchotte, V, Feron, JG, Morice, P, Deutsch, E, Wimberger, P, Classe, J-M, Gleeson, N, Leyen, HVD, Minsat, M, Dubot, C, Gestraud, P, Kereszt, A, Nagy, I, Balint, B, Berns, E, Jordanova, E, de Saint-Jorre, N, Savignoni, A, Servant, N, Hupe, P, de Koning, L, Fumoleau, P, Rouzier, R, Kamal, M & Guyon, F 2020, 'Corrigendum to ‘clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome’ (EBioMedicine (2019) 43 (253–260), (S2352396419302142), (10.1016/j.ebiom.2019.03.069)): Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome’ (EBioMedicine (2019) 43 (253–260), (S2352396419302142), (10.1016/j.ebiom.2019.03.069))', EBioMedicine, vol. 57, 102875. https://doi.org/10.1016/j.ebiom.2020.102875

Corrigendum to ‘clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome’ (EBioMedicine (2019) 43 (253–260), (S2352396419302142), (10.1016/j.ebiom.2019.03.069)): Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome’ (EBioMedicine (2019) 43 (253–260), (S2352396419302142), (10.1016/j.ebiom.2019.03.069)). / Scholl, Suzy; Popovic, Marina; Rochefordiere, Anne de la et al.
In: EBioMedicine, Vol. 57, 102875, 01.07.2020.

Research output: Contribution to journal › Erratum/Corrigendum › Academic

TY - JOUR

T1 - Corrigendum to ‘clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome’ (EBioMedicine (2019) 43 (253–260), (S2352396419302142), (10.1016/j.ebiom.2019.03.069))

T2 - Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome’ (EBioMedicine (2019) 43 (253–260), (S2352396419302142), (10.1016/j.ebiom.2019.03.069))

AU - Scholl, Suzy

AU - Popovic, Marina

AU - Rochefordiere, Anne de la

AU - Girard, Elodie

AU - Dureau, Sylvain

AU - Mandic, Aljosa

AU - Koprivsek, Katarina

AU - Samet, Nina

AU - Craina, Marius

AU - Margan, Madalin

AU - Samuels, Sanne

AU - Zijlmans, Henry

AU - Kenter, Gemma

AU - Hillemanns, Peter

AU - Dema, Sorin

AU - Dema, Alis

AU - Malenkovic, Goran

AU - Djuran, Branislav

AU - Floquet, Anne

AU - Garbay, Delphine

AU - Guyon, Frédéric

AU - Colombo, Pierre Emmanuel

AU - Fabbro, Michel

AU - Kerr, Christine

AU - Ngo, Charlotte

AU - Lecuru, Fabrice

AU - del Campo, Eleonor Rivin

AU - Coutant, Charles

AU - Marchal, Frédéric

AU - Mesgouez-Nebout, Nathalie

AU - Fourchotte, Virginie

AU - Feron, Jean Guillaume

AU - Morice, Philippe

AU - Deutsch, Eric

AU - Wimberger, Pauline

AU - Classe, Jean-Marc

AU - Gleeson, Noreen

AU - Leyen, Heiko von der

AU - Minsat, Mathieu

AU - Dubot, Coraline

AU - Gestraud, Pierre

AU - Kereszt, Attila

AU - Nagy, Istvan

AU - Balint, Balazs

AU - Berns, Els

AU - Jordanova, Ekaterina

AU - de Saint-Jorre, Nicolas

AU - Savignoni, Alexia

AU - Servant, Nicolas

AU - Hupe, Philippe

AU - de Koning, Leanne

AU - Fumoleau, Pierre

AU - Rouzier, Roman

AU - Kamal, Maud

AU - Guyon, Federic

PY - 2020/7/1

Y1 - 2020/7/1

N2 - The authors wish to clarify that the authors Aljosa Mandic, Katarina Koprivsek, and Goran Malenkovic are also affiliated with Faculty of Medicine Novi Sad, University of Novi Sad, Serbia, as well as Gynecologic Oncology Department Clinic for Operative Oncology, Institute of Oncology of Vojvodina, Serbia.

AB - The authors wish to clarify that the authors Aljosa Mandic, Katarina Koprivsek, and Goran Malenkovic are also affiliated with Faculty of Medicine Novi Sad, University of Novi Sad, Serbia, as well as Gynecologic Oncology Department Clinic for Operative Oncology, Institute of Oncology of Vojvodina, Serbia.

UR - https://www.scopus.com/pages/publications/85087412276

UR - https://www.ncbi.nlm.nih.gov/pubmed/32650273

UR - https://www.scopus.com/pages/publications/85087412276

U2 - 10.1016/j.ebiom.2020.102875

DO - 10.1016/j.ebiom.2020.102875

M3 - Erratum/Corrigendum

C2 - 32650273

SN - 2352-3964

VL - 57

JO - EBioMedicine

JF - EBioMedicine

M1 - 102875

ER -

Scholl S, Popovic M, Rochefordiere ADL, Girard E, Dureau S, Mandic A et al. Corrigendum to ‘clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome’ (EBioMedicine (2019) 43 (253–260), (S2352396419302142), (10.1016/j.ebiom.2019.03.069)): Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome’ (EBioMedicine (2019) 43 (253–260), (S2352396419302142), (10.1016/j.ebiom.2019.03.069)). EBioMedicine. 2020 Jul 1;57:102875. doi: 10.1016/j.ebiom.2020.102875

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this